571P Preclinical evaluation of FAP-2286, a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP)

Autor:	J. Xiao, M. Paschke, T.C. Harding, A. Hoehne, F. Osterkamp, A. Schumann, A. Bredenbeck, N. Beindorff, A-M. Mohan, U. Reineke, A.D. Simmons, M. Nguyen, C. Smerling, D. Zboralski
Rok vydání:	2020
Předmět:	chemistry.chemical_classification Oncology Fibroblast activation protein alpha chemistry business.industry Targeted radionuclide therapy Cancer research Medicine Peptide Hematology business
Zdroj:	Annals of Oncology. 31:S488
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.685
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5fdadbdc06877cfccb97916f64075a97 https://doi.org/10.1016/j.annonc.2020.08.685 Zobrazit plný text záznamu